Initial public offering of BioInvent International AB (SE) — SEK 372 million

Carnegie acted as lead manager in the initial public offering of BioInvent International AB on Stockholmsbörsen. By use of its technology platform BioInvent International AB is a partner to pharmaceutical companies within therapeutic antibodies and antibodies for use as discovery tools. June, 2001.